Education
Academic Background-
M.Sc. Beni-Suef University, Egypt Pharmacology | Completed: 2015
Publications (49)
Selected Scholarly Contributions
Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance
2025
Emerging insights into the role of natural products and miRNAs in psoriasis: from pathophysiology to precision medicine
2025
Harnessing the power of miRNAs for precision diagnosis and treatment of male infertility
2025
Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities
2025
2025
Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953
2025
Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways
2025
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance
2025
Nanoparticle innovations in targeted cancer therapy: advancements in antibody–drug conjugates
2025
Unlocking the Potential of miRNAs in Sepsis Diagnosis and Prognosis: From Pathophysiology to Precision Medicine
2025
2025
Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment
2025
2025
A Review on miRNAs in Enteric Bacteria‐mediated Host Pathophysiology: Mechanisms and Implications
2025
Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer
2025
Innovative perspectives on glioblastoma: the emerging role of long non-coding RNAs
2025
The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease
2025
MicroRNAs in HIV infection: dual regulators of viral replication and host immunity
2025
Natural compounds as regulators of miRNAs: exploring a new avenue for treating brain cancer
2025
Exploring the molecular pathways of miRNAs in testicular cancer: from diagnosis to therapeutic innovations
2025
When oral health affects overall health: biofilms, dental infections, and emerging antimicrobial strategies
2025
SNP’s use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic
2025
2025
Global Perspectives on Coronary Artery Disease: The Emerging Role of miRNAs
2025
miRNAs as Biomarkers and Therapeutic Targets in Celiac Disease: Current Advances and Future Directions
2025
2025
Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123
2025
The role of miRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: Special highlights on nanotechnology-based therapy
2025
Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies
2025
miRNA dysregulation in depression: unraveling the interplay between neuroplasticity, HPA axis dysfunction, and neuroinflammation
2025
From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response
2024
The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosis
2024
Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay
2024
Quillaja saponin mitigates methotrexate-provoked renal injury; insight into Nrf-2/Keap-1 pathway modulation with suppression of oxidative stress and inflammation
2024
miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markers
2024
Cell cycle machinery in oncology: A comprehensive review of therapeutic targets
2024
Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches
2024
The multifaceted role of beta‐blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders
2024
Natural products and long noncoding RNA signatures in gallbladder cancer: a review focuses on pathogenesis, diagnosis, and drug resistance
2024
Unveiling citicoline's mechanisms and clinical relevance in the treatment of neuroinflammatory disorders
2024
LncRNAs orchestration of gastric cancer - particular emphasis on the etiology, diagnosis, and treatment resistance
2024
Emerging insights: miRNA modulation of ferroptosis pathways in lung cancer
2024
Natural compounds targeting miRNAs: a novel approach in oral cancer therapy
2024
2024
Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential
2024
BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis
2023
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
2023
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach
2023
Angiotensin inhibitors potentiate the hypoglycemic and antioxidant effects of gliclazide in rats.
Mustafa Ahmed Abdel-Reheim
2015